A new 'In Discussion With' episode features Sehar Shahid on why unlicensed retatrutide injections carry risk. The full episode is out now.
Recap by typeshit. Post by Facebook on Facebook.
Bikman argues the facial change reflects rapid weight loss in general and suggests using the drug as a short-term aid for carb cravings. His view, not settled fact.
A clip from CNN's Body Language where two doctors point to common missteps they say lead to side effects on GLP-1 drugs. The full episode is on CNN.
An NYU obesity doctor outlines what people considering Ozempic or similar drugs should watch for. It is a general explainer for anyone weighing the shots.
15:57
A video on Chinese supply behind the peptide trend and the open question of what is actually in the vials people buy.
Small studies suggest the drugs help people with MS lose weight without raising disease activity, but the review flags muscle loss and NAION eye risk.
Novo Nordisk is cutting what Wegovy costs in China, Polskie Radio reports. Tap through for the size of the cut and when it takes effect.
Loading…